Abstract:Background: Preinjury of peripheral nerves triggers dorsal root ganglia (DRG) axon regeneration, a biological change that is more pronounced in young mice than in old mice, but the complex mechanism has not been clearly explained. Here, we aim to gain insight into the mechanisms of axon regeneration after conditioning lesion in different age groups of mice, thereby providing effective therapeutic targets for central nervous system (CNS) injury. Methods: The microarray GSE58982 and GSE96051 were downloaded and analyzed to identify differentially expressed genes (DEGs). The protein-protein interaction (PPI) network, the miRNA-TF-target gene network, and the drug-hub gene network of conditioning lesion were constructed. The L4 and L5 DRGs, which were previously axotomized by the sciatic nerve conditioning lesions, were harvested for qRT-PCR. Furthermore, histological and behavioral tests were performed to assess the therapeutic effects of the candidate drug telmisartan in spinal cord injury (SCI). Results: A total of 693 and 885 DEGs were screened in the old and young mice, respectively. Functional enrichment indicates that shared DEGs are involved in the inflammatory response, innate immune response, and ion transport. QRT-PCR results showed that in DRGs with preinjury of peripheral nerve, Timp1, P2ry6, Nckap1l, Csf1, Ccl9, Anxa1, and C3 were upregulated, while Agtr1a was downregulated. Based on the bioinformatics analysis of DRG after conditioning lesion, Agtr1a was selected as a potential therapeutic target for the SCI treatment. In vivo experiments showed that telmisartan promoted axonal regeneration after SCI by downregulating AGTR1 expression. Conclusion: This study provides a comprehensive map of transcriptional changes that discriminate between young and old DRGs in response to injury. The hub genes and their related drugs that may affect the axonal regeneration program after conditioning lesion were identified. These findings revealed the speculative pathogenic mechanism involved in conditioning-dependent regenerative growth and may have translational significance for the development of CNS injury treatment in the future.

Trim32 Affects the Recovery of Motor Function Following Spinal Cord Injury Through Regulating Proliferation of Glia

Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury

Epidermal Growth Factor Receptor-Extracellular-regulated Kinase Blockade Upregulates TRIM32 Signaling Cascade and Promotes Neurogenesis after Spinal Cord Injury

Knockdown of Polypyrimidine Tract Binding Protein Facilitates Motor Function Recovery after Spinal Cord Injury.

EGFR-ERK Blockade Upregulates TRIM32 Signalling Cascade and Promotes Neurogenesis after Spinal Cord Injury

Deficiency of TRIM32 Impairs Motor Function and Purkinje Cells in Mid-Aged Mice

Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury.

Ezrin Inhibition Alleviates Oxidative Stress and Pyroptosis Via Regulating TRPML1-calcineurin Axis Mediated Enhancement of Autophagy in Spinal Cord Injury

Triptolide Promotes the Repair of Spinal Cord Injury by Inhibiting Autophagy in Rats Models

TRIM21-mediated ubiquitination of PLIN2 regulates neuronal lipid droplet accumulation after acute spinal cord injury

TRIM56 Modulates YBX1 Degradation to Ameliorate ZBP1‐Mediated Neuronal PANoptosis in Spinal Cord Injury

Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury

Ubiquitin ligase Triad1 promotes neurite outgrowth by inhibiting MDM2-mediated ubiquitination of the neuroprotective factor pleiotrophin

Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion

MAP‑1B, PACS‑2 and AHCYL1 Are Regulated by Mir‑34a/b/c and Mir‑449 in Neuroplasticity Following Traumatic Spinal Cord Injury in Rats: Preliminary Explorative Results from Microarray Data.

The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR

Transcriptome Analyses Reveal Molecular Mechanisms Underlying Functional Recovery after Spinal Cord Injury.

RETRACTED: Triad1 Promotes the Inflammatory Response and Neuronal Apoptosis to Aggravate Acute Spinal Cord Injury in Rats (Retracted Article)

TRIM32 Deficiency Impairs Synaptic Plasticity by Excitatory-Inhibitory Imbalance Via Notch Pathway.

TRIM32 Deficiency Impairs the Generation of Pyramidal Neurons in Developing Cerebral Cortex

GSK-3 Inhibitor Promotes Neuronal Cell Regeneration and Functional Recovery in a Rat Model of Spinal Cord Injury.